Human defined antigenic region on the nucleoprotein of Crimean-Congo hemorrhagic fever virus identified using truncated proteins and a bioinformatics approach

被引:26
|
作者
Burt, F. J. [1 ,2 ]
Samudzi, R. R. [1 ]
Randall, C. [1 ]
Pieters, D. [1 ]
Vermeulen, J. [1 ]
Knox, C. M. [3 ]
机构
[1] Univ Orange Free State, Fac Hlth Sci, Dept Med Microbiol & Virol, ZA-9300 Bloemfontein, South Africa
[2] Universitas, Natl Hlth Lab Serv, ZA-9300 Bloemfontein, South Africa
[3] Rhodes Univ, Dept Biochem Microbiol & Biotechnol, ZA-6140 Grahamstown, South Africa
关键词
Crimean-Congo hemorrhagic fever virus; Antigenicity; Nucleoprotein; PEPTIDES; EXPRESSION; EPITOPES;
D O I
10.1016/j.jviromet.2013.07.055
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Crimean-Congo hemorrhagic fever virus (CCHFV) is a tick-borne viral zoonosis widely distributed in Africa, Asia and eastern Europe. In this study, amino acid sequence data for the CCHFV nucleoprotein (NP) was used to identify potential linear epitopic regions which were subsequently included in the design of large and small truncated recombinant NP antigens and peptide libraries. Two truncated recombinant CCHFV NP antigens were prepared based on results of prediction studies to include epitopic regions and exclude hydrophobic regions that could influence protein expression and solubility. Serum samples were collected from acute and convalescent patients. An IgG antibody response was detected in 16/16 samples tested using the large recombinant NP-based ELISA and in 2/16 using the small recombinant NP-based ELISA. A total of 60 peptides covering predicted epitopic regions of the NP were synthesized and peptide NRGGDENPRGPVSR at amino acid position 182-195, reacted with 13/16 human serum samples. In summary, functional assays are required to determine the biological activity of predicted epitopes for development of peptide based assays for antibody detection. Bacterially expressed complete NP antigens have previously been shown to be useful tools for antibody detection. Truncation of the antigen to remove the hydrophobic C terminus had no impact on the ability of the antigen to detect IgG antibody in human sera. The results indicate that the region from amino acids 123 to 396 includes a highly antigenic region of the NP with application in development of antibody detection assays. (C) 2013 Elsevier B.V. All rights reserved.
引用
收藏
页码:706 / 712
页数:7
相关论文
共 50 条
  • [41] Identification of broadly neutralizing monoclonal antibodies against Crimean-Congo hemorrhagic fever virus
    Zivcec, Marko
    Guerrero, Lisa I. W.
    Albarino, Cesar G.
    Bergeron, Eric
    Nichol, Stuart T.
    Spiropoulou, Christina F.
    ANTIVIRAL RESEARCH, 2017, 146 : 112 - 120
  • [42] Molecular characterization of small and medium segments of Crimean-Congo hemorrhagic fever virus in Turkey
    Karamese, Murat
    Ozmen, Erkan
    Aydin, Hakan
    Timurkan, Mehmet Ozkan
    Fakirullahoglu, Mesud
    FUTURE VIROLOGY, 2020, 15 (04) : 247 - 254
  • [43] Tick Cell Lines for Study of Crimean-Congo Hemorrhagic Fever Virus and Other Arboviruses
    Bell-Sakyi, Lesley
    Kohl, Alain
    Bente, Dennis A.
    Fazakerley, John K.
    VECTOR-BORNE AND ZOONOTIC DISEASES, 2012, 12 (09) : 769 - 781
  • [44] Crimean-Congo Hemorrhagic Fever Virus-Specific Antibody Detection in Cattle in Mauritania
    Sas, Miriam A.
    Mertens, Marc
    Isselmou, Ekaterina
    Reimer, Nicole
    El Mamy, Bezeid O.
    Doumbia, Baba
    Groschup, Martin H.
    VECTOR-BORNE AND ZOONOTIC DISEASES, 2017, 17 (08) : 582 - 587
  • [45] Crimean-Congo Hemorrhagic Fever Virus: An Emerging Threat in Europe with a Focus on Epidemiology in Spain
    Eslava, Maria
    Carlos, Silvia
    Reina, Gabriel
    PATHOGENS, 2024, 13 (09):
  • [46] Molecular detection of Crimean-Congo hemorrhagic fever virus in ticks, Greece, 2012–2014
    Anna Papa
    Anastasia Kontana
    Katerina Tsioka
    Ilias Chaligiannis
    Smaragda Sotiraki
    Parasitology Research, 2017, 116 : 3057 - 3063
  • [47] A simple assay for determining antiviral activity against Crimean-Congo hemorrhagic fever virus
    Paragas, J
    Whitehouse, CA
    Endy, TP
    Bray, M
    ANTIVIRAL RESEARCH, 2004, 62 (01) : 21 - 25
  • [48] Crimean-Congo Hemorrhagic Fever Virus: Current Advances and Future Prospects of Antiviral Strategies
    Dai, Shiyu
    Deng, Fei
    Wang, Hualin
    Ning, Yunjia
    VIRUSES-BASEL, 2021, 13 (07):
  • [49] Design and evaluation of neutralizing and fusion inhibitory peptides to Crimean-Congo hemorrhagic fever virus
    Mears, Megan C.
    Rodriguez, Sergio E.
    Schmitz, Katharina S.
    Padilla, Angel
    Biswas, Sudipta
    Cajimat, Maria N. B.
    Mire, Chad E.
    Welch, Stephen R.
    Bergeron, Eric
    Alabi, Christopher A.
    Porotto, Matteo
    Bente, Dennis A.
    ANTIVIRAL RESEARCH, 2022, 207
  • [50] The Role of Nucleocapsid Protein (NP) in the Immunology of Crimean-Congo Hemorrhagic Fever Virus (CCHFV)
    Pirincal, Aysegul
    Doymaz, Mehmet Z.
    VIRUSES-BASEL, 2024, 16 (10):